Any industry that's undergoing as much change as biopharma is always looking for leadership. Old marketing practices are being blown apart, R&D is being subjected to emergency surgery, drug...
Big Pharma's decision to shift more of its R&D resources to Asia over the past few years has helped spur a subtle but significant erosion of the U.S.'s traditional dominance in the field.
Eli Lilly has signed on to collaborate on fruquintinib, committing to a package of $86.5 million in fees and milestones to partner on a tumor treatment which was put up on the deal table earlier this year.
Under CEO Robert Bradway, Amgen made an Asian expansion one of its top priorities this year, and it's followed through with a decision to set up a new research center in Shanghai.
The Chinese said they wouldn't ignore home-grown corruption in pharma. Now, that promise is fulfilled. State-owned television network CCTV broadcast bribery allegations against a unit of Sino Biopharmaceutical, saying the company sent doctors on vacations abroad to boost sales of its drugs.
China venture group BVCF stepped in to lead the round, supported by existing investors Morningside Group and Devon Park Bioventures. They're backing the parallel development of MRX-I, an oral oxazolidinone antibiotic targeting infections triggered by multi-drug resistant Gram-positive bacteria, in the U.S. and China.
OrbiMed Advisors, an active biotech investor, is apparently scaling down plans for a new pan-Asian fund. OrbiMed Asia filed documents with the SEC for a proposed $300 million fund, well under the $500 million its partners were discussing back at the beginning of the year.
Chinese officials say they're stepping up their pharma investigation even further.
GlaxoSmithKline wasn't the only Big Pharma company to set up R&D operations in China. But a feature in Bloomberg today highlights GSK's unusual decision to give its China research division the lead in its neuroscience drug development effort.
Big Pharma companies are fighting to stay out of the spotlight as authorities show up to visit them.